Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)
戊酮、环磷酰胺和利妥昔单抗序贯阿仑单抗治疗复发或难治性慢性淋巴细胞白血病:ECOG-Acrin癌症研究组的2期试验(E2903)
期刊:Acta Haematologica
影响因子:1.1
doi:10.1159/000500164
Kempin, Sanford; Sun, Zhuoxin; Kay, Neil E; Paietta, Elisabeth M; Mazza, Joseph J; Ketterling, Rhett P; Frankfurt, Olga; Claxton, David F; Saltzman, Joel N; Srkalovic, Gordan; Callander, Natalie S; Gross, Gerald; Tallman, Martin S